Transit time affects the community stability of Lactobacillus and Bifidobacterium species in an in vitro model of human colonic microbiotia

Artificial Cells, Blood Substitutes, and Biotechnology

Volumn 39, Issue 6, 2011, Pages 351-356

  Rodes, Laetitia ^a   Paul, Arghya ^a   Coussa Charley, Michael ^a   Al Salami, Hani ^a   Tomaro Duchesneau, Catherine ^a   Fakhoury, Marc ^a   Prakash, Satya ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

Bifidobacteria; community stability; gut microbiota; Lactobacilli; model; PCR; probiotics; retention time

Indexed keywords

BIFIDOBACTERIA; COMMUNITY STABILITY; GUT MICROBIOTA; LACTOBACILLI; PCR; PROBIOTICS; RETENTION TIME;

BACILLI; BACTERIOLOGY; ENZYME INHIBITION;

STABILITY;

PROBIOTIC AGENT;

ADULT; ARTICLE; BACTERIAL CELL; BACTERIAL COUNT; BACTERIAL VIABILITY; BIFIDOBACTERIUM; CELL VIABILITY; CLOSTRIDIUM; COLON FLORA; CONTROLLED STUDY; DRUG RETENTION; ENTEROCOCCUS; HUMAN; HUMAN TISSUE; IN VITRO STUDY; INTESTINE TRANSIT TIME; LACTOBACILLUS; MICROBIAL COMMUNITY; NONHUMAN; NORMAL HUMAN; PLATE COUNT; POLYMERASE CHAIN REACTION; STAPHYLOCOCCUS;

BIFIDOBACTERIUM; COLON; COLONY COUNT, MICROBIAL; DNA, BACTERIAL; FERMENTATION; GASTROINTESTINAL TRANSIT; HUMANS; LACTOBACILLUS; METAGENOME; MICROBIAL VIABILITY; POLYMERASE CHAIN REACTION; TIME FACTORS;

BACTERIA (MICROORGANISMS); BIFIDOBACTERIUM; CLOSTRIDIA; LACTOBACILLUS; STAPHYLOCOCCUS;

EID: 80955142415     PISSN: 10731199     EISSN: 15324184     Source Type: Journal    
DOI: 10.3109/10731199.2011.622280     Document Type: Article

References (31)

1. Round, J.L., Mazmanian, S.K. (2009). The gut microbiota shapes intestinal immune responses during health and disease. Nat Rev Immunol 9 (5):313-23.
2. Salzman, N.H., Underwood, M.A., Bevins, C.L. (2007). Paneth cells, defensins, and the commensal microbiota: a hypothesis on intimate interplay at the intestinal mucosa. Semin Immunol 19 (2):70-83. (Pubitemid 46824070)
3. Macfarlane, S., Steed, H., Macfarlane, G.T. (2009). Intestinal bacteria and infl ammatory bowel disease. Crit Rev Clin Lab Sci 46 (1):25-54.
4. Peterson, D.A., Frank, D.N., Pace, N.R., Gordon, J.I. (2008). Metagenomic approaches for defi ning the pathogenesis of infl ammatory bowel diseases. Cell Host Microbe 3 (6):417-27. (Pubitemid 351773097)
5. Si, J.M., Yu, Y.C., Fan, Y.J., Chen, S.J. (2004). Intestinal microecology and quality of life in irritable bowel syndrome patients. World J Gastroenterol 10 (12):1802-5.
6. Kerckhoffs, A.P., Samsom, M., van der Rest, M.E., De, V.J., Knol, J., Ben-Amor, K., Akkermans, L.M. (2009). Lower bifi dobacteria counts in both duodenal mucosa-associated and fecal microbiota in irritable bowel syndrome patients. World J Gastroenterol 15 (23):2887-92.
7. Moore, W.E., Moore, L.H. (1995). Intestinal fl oras of populations that have a high risk of colon cancer. Appl Environ Microbiol 61 (9):3202-7.
8. Scanlan, P.D., Shanahan, F., Clune, Y., Collins, J.K., O'Sullivan, G.C., O'Riordan, M., Holmes, E., Wang, Y., Marchesi, J.R. (2008). Culture-independent analysis of the gut microbiota in colorectal cancer and polyposis. Environ Microbiol 10 (3):789-98. (Pubitemid 351160918)
9. Orrhage, K., Nord, C.E. (2000). Bifi dobacteria and lactobacilli in human health. Drugs Exp Clin Res 26 (3):95-111. (Pubitemid 30479604)
10. Gareau, M.G., Sherman, P.M., Walker, W.A. (2010). Probiotics and the gut microbiota in intestinal health and disease. Nat Rev Gastroenterol Hepatol 7 (9):503-14.
11. Child, M.W., Kennedy, A., Walker, A.W., Bahrami, B., Macfarlane, S., Macfarlane, G.T. (2006). Studies on the effect of system retention time on bacterial populations colonizing a three-stage continuous culture model of the human large gut using FISH techniques. FEMS Microbiol Eco l 55 (2):299-310.
12. Macfarlane, G.T., Macfarlane, S., Gibson, G.R. (1998). Validation of a Three-stage compound continuous culture system for investigating the effect of retention time on the ecology and metabolism of bacteria in the human colon. Microb Ecol 35 (2):180-7. (Pubitemid 28190244)
13. Molly, K., Vande, W.M., Verstraete, W. (1993). Development of a 5-step multi-chamber reactor as a simulation of the human intestinal microbial ecosystem. Appl Microbiol Biotechnol 39 (2):254-8. (Pubitemid 23134616)
14. Possemiers, S., Verthe, K., Uyttendaele, S., Verstraete, W. (2004). PCR-DGGE-based quantifi cation of stability of the microbial community in a simulator of the human intestinal microbial ecosystem. FEMS Microbiol Ecol 49 (3):495-507. (Pubitemid 39119606)
15. Macfarlane, G.T., Macfarlane, S., Gibson, G.R. (1998). Validation of a three-stage compound continuous culture system for investigating the effect of retention time on the ecology and metabolism of bacteria in the human colon. Microb Ecol 35 (2):180-7. (Pubitemid 28190244)
16. Martoni, C., Bhathena, J., Jones, M.L., Urbanska, A.M., Chen, H., Prakash, S. (2007). Investigation of microencapsulated BSH active lactobacillus in the simulated human GI tract. J Biomed Biotechnol 2007 (7):13684.
17. Bhathena, J., Kulamarva, A., Martoni, C., Urbanska, A.M., Prakash, S. (2008). Preparation and in vitro analysis of microencapsulated live lactobacillus fermentum 11976 for augmentation of feruloyl esterase in the gastrointestinal tract. Biotechnol Appl Biochem 50 (Pt 1):1-9. (Pubitemid 351631828)
18. McConnell, E.L., Fadda, H.M., Basit, A.W. (2008). Gut instincts: Explorations in intestinal physiology and drug delivery. Int J Pharm 364 (2):213-26.
19. Gill, S.R., Pop, M., Deboy, R.T., Eckburg, P.B., Turnbaugh, P.J., Samuel, B.S., Gordon, J.I., Relman, D.A., Fraser- Liggett, C.M., Nelson, K.E. (2006). Metagenomic analysis of the human distal gut microbiome. Science 312 (5778): 1355-9. (Pubitemid 43839542)
20. Hartemink, R., Kok, B.J., Weenk, G.H., Round, J.L. (1996). Raffi nose-Bifi dobacterium (RB) agar, a new selective medium for bifi dobacteria. J Microbiol Methods 27 :33-43. (Pubitemid 26375862)
21. Hartemink, R., Domenech, V.R., Rombouts, F.M. (1997). LAMVAB - A new selective medium for the isolation of lactobacilli from faeces. J Microbiol Methods 29 :77-84. (Pubitemid 27319830)
22. Muyzer, G., de Waal, E.C., Uitterlinden, A.G. (1993). Profi ling of complex microbial populations by denaturing gradient gel electrophoresis analysis of polymerase chain reaction-amplifi ed genes coding for 16S rRNA. Appl Environ Microbiol 59 (3):695-700. (Pubitemid 23072343)
23. Rinttila, T., Kassinen, A., Malinen, E., Krogius, L., Palva, A. (2004). Development of an extensive set of 16S rDNAtargeted primers for quantifi cation of pathogenic and indigenous bacteria in faecal samples by real-time PCR. J Appl Microbiol 97 (6):1166-77. (Pubitemid 39573940)
24. Satokari, R.M., Vaughan, E.E., Akkermans, A.D., Saarela, M., de Vos, W.M. (2001). Bifi dobacterial diversity in human feces detected by genus-specifi c PCR and denaturing gradient gel electrophoresis. Appl Environ Microbiol 67 (2): 504-13. (Pubitemid 32121335)
25. Sekirov, I., Russell, S.L., Antunes, L.C., Finlay, B.B. (2010). Gut microbiota in health and disease. Physiol Rev 90 (3):859-904.
26. O'Hara, A.M., Shanahan, F. (2006). The gut fl ora as a forgotten organ. EMBO Rep 7 (7):688-93. (Pubitemid 43986264)
27. FAO/WHO. (2001). Health and nutritional properties of probiotics in food including powder milk with live lactic acid bacteria. Report of a Joint FAO/WHO Expert Consultation on Evaluation of Health and Nutritional Properties of Probiotics in Food Including Powder Milk with Live Lactic Acid Bacteria . Basel, Switzerland: World Heatlh Organization.
28. Kleerebezem, M., Vaughan, E.E. (2009). Probiotic and gut lactobacilli and bifi dobacteria: Molecular approaches to study diversity and activity. Annu Rev Microbiol 63 :269-90.
29. Hormannsperger, G., Haller, D. (2010). Molecular crosstalk of probiotic bacteria with the intestinal immune system: Clinical relevance in the context of infl ammatory bowel disease. Int J Med Microbiol 300 (1):63-73.
30. Gill, H., Prasad, J. (2008). Probiotics, immunomodulation, and health benefi ts. Adv Exp Med Biol 606 :423-54.
31. Kalliomaki, M., Salminen, S., Isolauri, E. (2008). Positive interactions with the microbiota: Probiotics. Adv Exp Med Biol 635 :57-66.